Search Results 741-750 of 16705 for astragalus dosage

  1. A Study To Evaluate The Safety And Efficacy Of Two Dose Levels Of ONO-4578 With Opdivo®, In Combination With MFOLFOX6 And Bevacizumab Versus Standard Of Care In Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer - Mayo Clinic

    A Study To Evaluate The Safety And Efficacy Of Two Dose Levels Of ONO-4578 With Opdivo®, In Combination With MFOLFOX6 And Bevacizumab Versus Standard Of ...

  2. Mirvetuximab soravtansine-gynx (intravenous route) - Side effects & uses - Mayo Clinic

    This product is available in the following dosage forms: Solution. Back to ... In these cases, your doctor may want to change the dose, or other precautions may ...

  3. Brexucabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important ...

  4. Mayo Clinic

    This is a highly targeted and precise way of administering radiation therapy. It allows delivery of higher doses of radiation to tumors while minimizing the ...

  5. Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors - Mayo Clinic

    ... dose anthracyclines for management of childhood cancer. Patients who received high-dose anthracycline chemotherapy are at a much greater risk for developing ...

  6. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    Part A (dose regimen finding) will involve dose escalation and possible dose interval modification to define the maximum tolerated dose (MTD) and/or recommended ...

  7. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  8. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    ... dose (MTD)/recommended phase 2 dose (RP2D) of APG-2575, alone or in combination with other therapeutic agents (ibrutinib or rituximab), in patients with ...

  9. Etranacogene dezaparvovec-drlb (intravenous route) - Side effects & uses - Mayo Clinic

    In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other ...

  10. Clinical trials - Oncology (Medical)

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...